Read on Twitter
1/ Thanks so much for the invitation to speak at #2020SHPAVCON on take-home #naloxone in hospital settings. It has been recorded by @the_shpa .. but here are a few take-away messages:
2/ Firstly - there is now an @the_shpa Practice Update to support #naloxone supply in hospitals - check it out!
#naloxone is relevant for many populations - people attending ED with opioid toxicity are a key group, but not the only important group
There are a range of risk-factors to consider when identifying key populations among people prescribed opioids who could benefit from opioid-safety education and take-home #naloxone
4/ Consider the information needs of the person in front of you. Many people who inject drugs already have much knowledge - but have also experienced considerable stigma in the healthcare system -> we need to consider this in our approach and language
5/ Some resources are here https://www.penington.org.au/cope-overdose-first-aid/
6/ Resources specifically developed with people prescribed opioids for pain are here - download leaflets and animations for pharmacist and patient education here - FREE: https://www.monash.edu/medicine/ehcs/marc/research/current/opioid-safety
